Here's a look at some of the top Wall Street stories for medical device companies this week: TriVascular Tech's stent graft recall could hurt the bottom line; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules; Baxano puts itself on the auction block; Philips to carve out lighting biz, merger healthcare & consumer units
TriVascular Tech's stent graft recall could hurt the bottom line
September 19, 2014 by Arezu Sarvestani
Baxano Surgical, Covidien, Houlihan Lokey, Medtronic, Philips Healthcare, TriVascular, U.S. Treasury Dept., Alere
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/ZQIqTq
Cap comentari:
Publica un comentari a l'entrada